ClinicalTrials.Veeva

Menu

Long COVID Symptoms in SARS-CoV-2-positive Children in China

T

Tim Shi

Status

Active, not recruiting

Conditions

Symptoms and Signs

Treatments

Other: SBQ-LC survey

Study type

Observational

Funder types

Other

Identifiers

NCT05729217
Children COVID Symptoms

Details and patient eligibility

About

The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes. The participants will be asked to fill in Long COVID symptom burden questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive.

Full description

The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes.

The participants will be asked to fill in SBQ-Long COVID symptom burden survey questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive.

The survey questionnaires will be filled every two weeks after the participants have been tested SARS-CoV-2 positive.

Enrollment

5,000 estimated patients

Sex

All

Ages

7 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

infected with SARS-CoV-2 as self-reported PRC test or antigen test positive or have symptoms, but without Covid-19 test.

Exclusion criteria

aged below 6 years or above 18 years

Trial design

5,000 participants in 3 patient groups

Group 1 aged 7-12 years
Description:
Group 1 will mainly be primary school students from grade 1 to 6.
Treatment:
Other: SBQ-LC survey
Group 2 aged 13-15 years
Description:
Group 2 will mainly be middle school students from grade 13 to 15.
Treatment:
Other: SBQ-LC survey
Group 2 aged 16-18 years
Description:
Group 3 will mainly be high school students from grade 16 to 18.
Treatment:
Other: SBQ-LC survey

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems